Skip to main content
SpringerLink
Log in
Book cover

Erkrankungen des Pankreas pp 211–215Cite as

Klinische Manifestationen endokriner Tumoren des Pankreas

  • Chapter
  • First Online:

  • 3751 Accesses

Zusammenfassung

Endokrine Pankreastumoren sind im Vergleich zum Pankreaskarzinom seltene Tumoren. Ihre Häufigkeit nimmt in der westlichen Welt zu, und bedingt durch die günstige Prognose steigt die Zahl der Betroffenen. Die Klinik von Insulinom und Gastrinom kann bereits zielführend sein; in Teilen gilt dies auch für die seltenen Entitäten wie zum Beispiel das VIPom und auch das Glukagonom. Vielfach ist das klinische Bild jedoch nicht zwingend typisch für das Vorliegen eines neuroendokrinen Pankreastumors. Insbesondere die nicht sezernierenden neuroendokrinen Pankreastumoren werden mehrheitlich als Zufallstumor (Inzidentalom) oder erst durch ihren Volumeneffekt klinisch apparent.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Alexandraki KI, Grossman AB (2010) The ectopic ACTH syndrome. Rev Endocr Metab Disord 11: 117–126

    Article  PubMed  Google Scholar 

  • Alsever RN, Roberts JP, Gerber JG, Mako ME, Rubenstein AH (1975) Insulinoma with low circulating insulin levels: the diagnostic value of proinsulin measurements. Ann Intern Med 82(3): 347–350

    Article  PubMed  CAS  Google Scholar 

  • Asa SL, Kovacs K, Killinger DW, Marcon N, Platts M (1980) Pancreatic islet cell carcinoma producing gastrin, ACTH, α-endorphin, somatostatin and calcitonin. Am J Gastroenterol 74: 30–35

    PubMed  CAS  Google Scholar 

  • Bassett JHD, Williamson C, Pang J et al (1997) Glucagonomas in multiple endocrine neoplasia type 1. J Endocrinol 152: 68

    Google Scholar 

  • Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658–5671

    Article  PubMed  CAS  Google Scholar 

  • Friesen SR, Allen MS (1975) Malignant hyperparathyroidism of pancreatic and parathyroid origins. Bull Soc Int Chir 5: 439–441

    Google Scholar 

  • Friesen SR, Hermreck AS, Mantz FA Jr (1974) Glucagon, gastrin, and carcinoid tumors of the duodenum, pancreas, and stomach: polypeptide „apudomas“ of the foregut. Am J Surg 127: 90–101

    Article  PubMed  CAS  Google Scholar 

  • Friesen SR, Kimmel JR, Tomita T (1980) Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies. Am J Surg 139(1): 61–72

    Article  PubMed  CAS  Google Scholar 

  • Friesen SR, McGuigan JE (1975) Ectopic apudocarcinomus and associated endocrine hyperplasias of the foregut. Ann Surg 182: 371–385

    Article  PubMed  CAS  Google Scholar 

  • Grama D, Skogseid B, Wilander E et al (1992) Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World J Surg 16: 611–619

    Article  PubMed  CAS  Google Scholar 

  • Hammar S, Sale G (1975) Multiple hormone producing islet cell carcinomas of the pancreas. A morphological and biochemical investigation. Hum Pathol 6: 349–362

    Article  PubMed  CAS  Google Scholar 

  • Jensen RT, Norton JA (2010) Endocrine tumors of the pancreas and the gastrointestinal tract. In: Feldman M, Friedman LS, Bradt LJ (Hrsg) Sleisinger and Fordtran’s gastrointestinal and liver disease, 9. Aufl. W.B. Saunders, Philadelphia, S 491–523

    Google Scholar 

  • Kaplan EL, Michelassi F (1986) Endocrine tumors of the pancreas and their clinical syndromes. Surg Annu 18: 181–223

    PubMed  CAS  Google Scholar 

  • Karges W, Ludwig L, Kessler H, Wissmann A, Wagner PK, Boehm BO (1998) Menin mutations in the diagnosis and prediction of multiple endocrine neoplasia type 1. Langenbecks Arch Surg 383(2): 183–186

    Article  PubMed  CAS  Google Scholar 

  • Karges W, Schaaf L, Dralle H, Boehm BO (2002) Clinical and molecular diagnosis of multiple endocrine neoplasia type 1. Langenbecks Arch Surg 386(8): 547–552

    Article  PubMed  Google Scholar 

  • Krejs GJ, Orci L, Conlon JM et al (1979) Somatostatinoma syndrome: biochemical, morphologic and clinical features. N Engl J Med 301: 285–292

    Article  PubMed  CAS  Google Scholar 

  • Kulke MH, Benson AB 3rd, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, Clark OH, Doherty GM, Eason J, Emerson L, Engstrom PF, Goldner WS, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW 2nd, Moley JF, Pillarisetty VG, Saltz L, Schteingart DE, Shah MH, Shibata S, Strosberg JR, Vauthey JN, White R, Yao JC, Freedman-Cass DA, Dwyer MA (2012) National Comprehensive Cancer Networks. Neuroendocrine tumors. J Natl Compr Canc Netw 10(6): 724–764

    PubMed  CAS  Google Scholar 

  • Lamers CB, Buis JT, van Tongeren J (1977) Secretin-stimulated serum gastrin levels in hyperparathyroid patients from families with multiple endocrine adenomatosis type I. Ann Intern Med 86(6): 719–724

    Article  PubMed  CAS  Google Scholar 

  • Larsson L-I, Hirsch MA, Holst JJ et al (1977) Pancreatic somatostatinoma: clinical features and physiological implications. Lancet 1: 666–668

    Article  PubMed  CAS  Google Scholar 

  • Lowney JK, Frisella MM, Lairmore TC, Doherty GM (1998) Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size. Surgery 124: 1043–1049

    Article  PubMed  CAS  Google Scholar 

  • Mallinson C, Bloom SR (1978) The hyperglycemic, cutaneous syndrome: pancreatic glucagonoma. In: Friesen SR (Hrsg) Surgical endocrinology: clinical syndromes. JB Lippincott, Philadelphia, S 171–202

    Google Scholar 

  • Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B (1974) A glucagonoma syndrome. Lancet 2: 1–5

    Article  PubMed  CAS  Google Scholar 

  • McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME (1966) A glueagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med 274: 1408–1413

    Article  PubMed  CAS  Google Scholar 

  • Mozell E, Stenzel P, Woltering EA, Rösch J, O’Dorisio TM (1990) Functional endocrine tumors of the pancreas: clinical presentation, diagnosis, and treatment. Curr Probl Surg 27(6): 301–386

    Article  PubMed  CAS  Google Scholar 

  • O’Dorisio T, Vinik A (1985) Pancreatic polypeptide and mixed peptide-producing tumors of the gastrointestinal tract. In: Cohen S, Soloway RD (Hrsg) Contemporary Issues in Gastroenterology, Churchill-Livingstone, New York

    Google Scholar 

  • Ohneda A, Otsuki M, Fujiya H, Yaginuma N, Kokubo T, Ohtani H (1979) A malignant insulinoma transformed into a glucagonoma syndrome. Diabetes 28: 962–969

    Article  PubMed  CAS  Google Scholar 

  • Polak JM, Bloom SR, Adrian TE, Heitz P, Bryant MG, Pearse AG (1976) Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet 1(7955) 328–330

    Article  PubMed  CAS  Google Scholar 

  • Polak JM, Pearse AGF, Grimelius L, Bloom SR, Arimura A (1975) Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet 1: 1220–1222

    Article  PubMed  CAS  Google Scholar 

  • Rizzoli R, Sappino AP, Bonjour JP (1990) Parathyroid hormone-related protein and hypercalcemia in pancreatic neuro-endocrine tumors. Int J Cancer 46(3): 394–398

    Article  PubMed  CAS  Google Scholar 

  • Roy PK, Venzon DJ, Shojamanesh H et al (2000) Zollinger-Ellison syndrome: clinical presentation in 261 patients. Medicine (Baltimore) 79: 379–411

    Article  CAS  Google Scholar 

  • Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9: 357–373

    Article  PubMed  CAS  Google Scholar 

  • Schaaf L (2003) Deutsche MEN1-Datenbank. Netzwerk Hypophysen- und Nebennierenerkrankungen, 4. Aufl. Erlangen

    Google Scholar 

  • Service FJ, Dale AJ, Elveback LR, Jiang NS (1976) Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc 51(7): 417–429

    Google Scholar 

  • Tricia A, Moo-Young, Prinz RA (2012) Endocrine tumors of the pancreas. In: Blumgart’s surgery of the liver, pancreas and biliary tract. Elsevier, S 934–944

    Google Scholar 

  • Unger RH (1977) Somatostatinoma. N Engl J Med 296: 998–1000

    Article  PubMed  CAS  Google Scholar 

  • Unger RH, Orci L (1981) Glucagon and the A cell: physiology and pathophysiology. N Engl J Med 304: 1518–1524, 1575–1580

    Article  PubMed  CAS  Google Scholar 

  • Vertier JV, Morrison AB (1958) Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 25: 374–380

    Article  Google Scholar 

  • Vieweg WV, Graber AL, Cerchio GM (1969) Pancreatic islet cell carcinoma with hyperinsulinism and probable, ectopic ACTH-MSH secretion. Arch Intern Med 124: 731–735

    Article  PubMed  CAS  Google Scholar 

  • Vinik A, Glaser B (1981) Pancreatic endocrine tumors. In: Pancreatic Disease [TL Dent], 427. Grune & Stratton, New York

    Google Scholar 

  • Weber KJ, Lin J, Prinz RA (2007) Endocrine tumors of the pancreas: clinical picture, diagnosis, and therapy. In: Surgery of the liver, biliary tract and pancreas. Elsevier, S 904–914

    Google Scholar 

  • Wermers RA, Fatourechi V, Kvols LK (1996) Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors. Mayo Clinic Proceedings 71(11): 1030–1038

    Article  PubMed  CAS  Google Scholar 

  • Whipple AO, Franz VK (1935) Adenoma of islet cells with hyperinsulinism. Am Surg 101: 1299–1335

    CAS  Google Scholar 

  • Wolfe MM, Jensen RT (1987) Zollinger-Ellison syndrome. Current concepts in diagnosis and management. N Engl J Med 317: 1200–1209

    Article  PubMed  CAS  Google Scholar 

  • Wynick D, Williams SJ, Bloom SR (1988) Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors. N Engl J Med 319: 605–607

    Article  PubMed  CAS  Google Scholar 

  • Yao JC, Eisner MP, Leary C et al (2007) Population-based study of islet cell carcinoma. Ann Surg Oncol 14: 3492–3500

    Article  PubMed  Google Scholar 

  • Yao JC, Hassan M, Phan A et al (2008) One hundred years after „carcinoid“: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26: 3063–3072

    Article  PubMed  Google Scholar 

  • Yao JC, Rindi G, Evans DB (2008) Pancreatic endocrine tumors. In: DeVita VT, Lawrence TS, Rosenberg SA (Hrsg) Cancer: principles and practice of oncology, 8. Aufl. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, S 1702–1721

    Google Scholar 

  • Yu F, Venzon DJ, Serrano J et al (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 17: 615–630

    PubMed  CAS  Google Scholar 

  • Zollinger RM, Ellison EH (1955) Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142: 709–723

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. LKC School of Medicine, Imperial College London, and NTU, Singapore, Deutschland

    Bernhard O. Böhm

Authors
  1. Bernhard O. Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernhard O. Böhm .

Editor information

Editors and Affiliations

  1. Abt. Allgemeine- und Visceralchirurgie, Universitätsklinikum Ulm, Germany

    Hans G. Beger

  2. Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg, Germany

    Markus W. Büchler

  3. Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Halle, Sachsen-Anhalt, Germany

    Henning Dralle

  4. Klinik und Poliklinik für Innere Medizin, Universitätsmedizin Greifswald, Germany

    Markus M. Lerch

  5. und Hepatologie (KGHI), Universitätsklinikum Magdeburg, Germany

    Peter Malfertheiner

  6. FB Gastroenterologie und Hepatologie, Universitätsklinikum Leipzig, Sachsen, Germany

    Joachim Mössner

  7. ehemals Klinikum der Stadt Ludwigshafen gGmbH, Rheinland-Pfalz, Germany

    Jürgen F. Riemann

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Böhm, B. (2013). Klinische Manifestationen endokriner Tumoren des Pankreas. In: Beger, H., et al. Erkrankungen des Pankreas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37964-2_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-37964-2_40

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-37963-5

  • Online ISBN: 978-3-642-37964-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation